Affinity Asset Advisors’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.4M | Sell |
970,000
-100,000
| -9% | -$1.48M | 1.96% | 13 |
|
|
2025
Q1 | $19.2M | Buy |
1,070,000
+870,000
| +435% | +$15.6M | 1.83% | 11 |
|
|
2024
Q4 | $3.48M | Buy |
+200,000
| New | +$3.48M | 0.47% | 39 |
|
|
2024
Q2 | – | Sell |
-125,000
| Closed | -$964K | – | 110 |
|
|
2024
Q1 | $964K | Buy |
+125,000
| New | +$964K | 0.12% | 68 |
|
|
2023
Q4 | – | Sell |
-100,000
| Closed | -$894K | – | 89 |
|
|
2023
Q3 | $894K | Buy |
+100,000
| New | +$894K | 0.25% | 54 |
|
|
2022
Q2 | – | Sell |
-100,000
| Closed | -$2.58M | – | 62 |
|
|
2022
Q1 | $2.58M | Buy |
100,000
+50,000
| +100% | +$1.29M | 0.41% | 28 |
|
|
2021
Q4 | $1.55M | Sell |
50,000
-150,000
| -75% | -$4.66M | 0.56% | 36 |
|
|
2021
Q3 | $4.85M | Buy |
+200,000
| New | +$4.85M | 1.22% | 18 |
|
|
2021
Q2 | – | Sell |
-220,000
| Closed | -$5.49M | – | 75 |
|
|
2021
Q1 | $5.49M | Buy |
+220,000
| New | +$5.49M | 1.87% | 10 |
|